99 related articles for article (PubMed ID: 23931063)
1. Nanosized aspirin-Arg-Gly-Asp-Val: delivery of aspirin to thrombus by the target carrier Arg-Gly-Asp-Val tetrapeptide.
Jin S; Wang Y; Zhu H; Wang Y; Zhao S; Zhao M; Liu J; Wu J; Gao W; Peng S
ACS Nano; 2013 Sep; 7(9):7664-73. PubMed ID: 23931063
[TBL] [Abstract][Full Text] [Related]
2. RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model.
Cadroy Y; Houghten RA; Hanson SR
J Clin Invest; 1989 Sep; 84(3):939-44. PubMed ID: 2760221
[TBL] [Abstract][Full Text] [Related]
3. The application of tetrahydroisoquinoline-3-carbonyl-TARGD(F)F as an anti-thrombotic agent having dual mechanisms of action.
Yang G; Zhu H; Zhao M; Wu J; Wang Y; Wang Y; Zheng M; Chen M; Liu J; Peng S
Mol Biosyst; 2012 Oct; 8(10):2672-9. PubMed ID: 22801714
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, nano-scale assembly, and in vivo anti-thrombotic activity of novel short peptides containing L-Arg and L-Asp or L-Glu.
Chen Y; Cui G; Zhao M; Wang C; Qian K; Morris-Natschke S; Lee KH; Peng S
Bioorg Med Chem; 2008 Jun; 16(11):5914-25. PubMed ID: 18495483
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg-Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis model.
Imura Y; Stassen JM; Bunting S; Stockmans F; Collen D
Blood; 1992 Sep; 80(5):1247-53. PubMed ID: 1515641
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic activity of Z4A5, a new platelet glycoprotein IIb/IIIa receptor antagonist evaluated in a rabbit arteriovenous shunt thrombosis model.
Jing BB; Li YX; Zhang H; Ren ST; Wang M; Li YP; Zang WJ; Wang B
Thromb Res; 2011 Nov; 128(5):463-9. PubMed ID: 21924458
[TBL] [Abstract][Full Text] [Related]
7. Endothelium-dependent vasorelaxant and anti-aggregatory effect and mechanism of action of some antifibrinogen RGD (Arg-Gly-Asp-containing) peptides.
Torday LL; Pataricza J; Balogh GE; Zarándi M; Penke B; Papp JG
J Pharm Pharmacol; 1998 Jun; 50(6):667-71. PubMed ID: 9680079
[TBL] [Abstract][Full Text] [Related]
8. Cu(2+)-RGDFRGDS: exploring the mechanism and high efficacy of the nanoparticle in antithrombotic therapy.
Wu J; Wang Y; Wang Y; Zhao M; Zhang X; Gui L; Zhao S; Zhu H; Zhao J; Peng S
Int J Nanomedicine; 2015; 10():2925-38. PubMed ID: 25931819
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeys.
Kaku S; Kawasaki T; Hisamichi N; Sakai Y; Taniuchi Y; Inagaki O; Yano S; Suzuki K; Terazaki C; Masuho Y; Satoh N; Takenaka T; Yanagi K; Ohshima N
Thromb Haemost; 1996 Apr; 75(4):679-84. PubMed ID: 8743199
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
Schrör K
Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA.
Wu J; Zhu H; Yang G; He J; Wang Y; Zhao S; Zhang X; Gui L; Zhao M; Peng S
Int J Nanomedicine; 2018; 13():1139-1158. PubMed ID: 29520141
[TBL] [Abstract][Full Text] [Related]
12. Novel Cu(II)-RGD-octapeptides: Synthesis, coordination mode, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and correlation of sequence with nano-structure.
Li N; Kang G; Gui L; Zhao M; Wang W; Zhang J; Yue YF; Peng S
Nanomedicine; 2011 Aug; 7(4):403-9. PubMed ID: 21272663
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the antithrombotic effects of FK633, GPIIb/IIIa antagonist, and aspirin in a guinea pig thrombosis model.
Aoki T; Cox D; Senzaki K; Seki J; Tanaka A; Takasugi H; Motoyama Y
Thromb Res; 1998 Feb; 89(3):129-36. PubMed ID: 9622041
[TBL] [Abstract][Full Text] [Related]
15. [Targeted adhesion of platelet receptor-specific microbubble agent to thrombus in vitro].
Ou WC; Xiu JC; Xie JG; Zha DG; Liu J; Hao R; Bin JP; Liu YL
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):672-4. PubMed ID: 15958305
[TBL] [Abstract][Full Text] [Related]
16. Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates.
Matsuno H; Kozawa O; Nagashima S; Kanamaru M; Uematsu T
Br J Pharmacol; 1999 Jul; 127(5):1129-34. PubMed ID: 10455258
[TBL] [Abstract][Full Text] [Related]
17. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo.
Herault JP; Peyrou V; Savi P; Bernat A; Herbert JM
Thromb Haemost; 1998 Feb; 79(2):383-8. PubMed ID: 9493595
[TBL] [Abstract][Full Text] [Related]
18. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
[TBL] [Abstract][Full Text] [Related]
19. Triflavin, an antiplatelet Arg-Gly-Asp-containing peptide, is a specific antagonist of platelet membrane glycoprotein IIb-IIIa complex.
Huang TF; Sheu JR; Teng CM; Chen SW; Liu CS
J Biochem; 1991 Feb; 109(2):328-34. PubMed ID: 1864844
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen sulfide-releasing aspirin derivative ACS14 exerts strong antithrombotic effects in vitro and in vivo.
Pircher J; Fochler F; Czermak T; Mannell H; Kraemer BF; Wörnle M; Sparatore A; Del Soldato P; Pohl U; Krötz F
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2884-91. PubMed ID: 23023375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
